Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 March 2021 | Story Ruan Bruwer | Photo Netball South Africa
Defender Refiloe Nketsa is one of four Kovsies chosen for the South African U21 netball team.

With no less than four Kovsies in the South African Under 21 netball team, the near future for this sport at the University of the Free State (UFS) is certainly on the bright side.

Chanel Vrey, Refiloe Nketsa, Rolene Streutker, and Boitumelo Mahloko will be in action for the Baby Proteas, as the team is known, in a challenge series. The team will battle the President’s XII (a South African A team) and Uganda from 25 March in Cape Town. 

They all played for the Free State senior side last year. Vrey and Streutker also played for the Baby Proteas against international competition in 2019.

Mahloko – a former Kovsie – and Nketsa have also represented South Africa at junior level in the past. They were team members in the national U16 team in 2017, and a year later Mahloko made the U20 team and Nketsa the SA U18 team.

Khanyisa Chawane will also be in action in the series, playing for the Proteas, while former Kovsie captain Alicia Puren has been chosen for the President’s XII.

Meanwhile, two hockey players, Saré Laubscher and Zimkhitha Weston, have been picked for the South African U21 women’s hockey team. They would have participated in the African qualifying tournament in Ghana at the end of March. This tournament has, however, been postponed to January 2022. 

This is the third consecutive year that Laubscher has made the team. Weston, a former Kovsie, played for South Africa at the 2018 Youth Olympic Games in Argentina.

The African Hockey Qualifier serves as qualification for the Junior World Cup, which is scheduled for December in Potchefstroom. South Africa has already qualified as hosts for the Junior World Cup, but the African crown is up for grabs in Ghana. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept